Gain Therapeutics, Inc. · NASDAQ:GANX
Gain Therapeutics, Inc. shareholders
As of Sep 30, 2026, 48 institutions reported holding Gain Therapeutics, Inc., 19.0% of its shares. Largest: Marshall Wace, LLP, Potomac Capital Management, Inc. and Jones Financial Companies Lllp. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Gain Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Marshall Wace, LLP | 1.68M | 3.8% | −243K | Nov 13, 2026 |
| Potomac Capital Management, Inc. | 930K | 2.1% | −16,400 | Nov 13, 2026 |
| Jones Financial Companies Lllp | 739K | 1.7% | +131K | Nov 13, 2026 |
| Vanguard | 730K | 1.6% | no change | Nov 13, 2026 |
| Gsa Capital Partners LLP | 635K | 1.4% | +2,585 | Nov 16, 2026 |
| Cambridge Investment Research Advisors, Inc. | 567K | 1.3% | −571K | Nov 2, 2026 |
| DME Capital Management, LP | 566K | 1.3% | no change | Nov 16, 2026 |
| Geode Capital | 470K | 1.1% | +16,034 | Nov 6, 2026 |
| BlackRock | 268K | 0.60% | −6,636 | Nov 13, 2026 |
| UBS | 241K | 0.54% | +26,471 | Nov 10, 2026 |